Delivery Order SPE2DR25D3005-SPE2DR26FP7RW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $29,158.33 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) on September 17, 2025, with completion targeted for September 18, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $87,963.69 and an ultimate completion date of December 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit of use packaging) under a firm fixed-price contract with a ceiling value of $10,448.17. This non-set-aside, competitively awarded delivery order has an ultimate completion date of December 17, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed price contract valued at $11,902.23. This is a non-set-aside competitive award with an ultimate completion date of December 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $32,555.23 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) under a firm fixed-price contract valued at $26,653.57, with completion scheduled for December 4, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, specifically supporting the Defense Logistics Agency's medical...
- The Defense Logistics Agency awarded a $13,012.76 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for supply of RINVOQ ER 15 mg tablets in quantities of 30-unit bottles. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $28,136.78 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 18, 2025, with completion targeted for November 19, 2025. This firm fixed-price delivery order was awarded competitively without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $12,659.47 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. The contract is a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $70,077.70 on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply role within the federal healthcare procurement system. The products will be delivered to the...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7RWDelivery Order
The Defense Logistics Agency awarded a $28,761.77 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for RINVOQ ER 15 mg tablets (30-unit packaging), with a completion date of December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, specifically supporting the Defense Logistics Agency's medical supply chain operations. This delivery order functions as a child contract under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad portfolio of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability in fulfilling federal medical procurement requirements through open competition positions it to continue serving critical pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.8k | 12/1/25 |